Expression of activation markers on peripheral-blood lymphocytes following oral administration of bacillus subtilis spores

This study was undertaken to assess the capability of Bacillus subtilis spores to modify the peripheral-blood lymphocyte (PBL) subsets or determine the de novo expression of activation markers. The data we obtained show that spores of B. subtilis are able to increase the expression of certain cell activation markers and that such activation is dose-dependent. In fact, doses of 2 × 109 spores did not give rise to changes in any of the parameters evaluated, while doses of 6 × 109 increased the HLA-DR antigen expression on T-lymphocytes. At the highest dosage used (12 × 109), B. subtilis spores caused the appearance of cells bearing the CD25 and CD71 activation markers. Therefore, such cell activation markers may prove useful for monitoring the activity of B. subtilis spores, and possibly of other immunomodulating agents, in the course of clinical research.